Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure a double-blind, randomized prospective study

18Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Double-blind, randomized controlled studies of longer than 1 week in duration comparing the antiproteinuric potential of long-acting dihydropyridine calcium channel blockers with that of angiotensin converting enzyme (ACE) inhibitors are lacking. Therefore, we performed such a study in patients with nondiabetic renal disease and proteinuria. After a 4-week wash- out period in which patients did not use any medication known to affect proteinuria, 21 patients were randomized in a double-blind fashion to receive either the calcium channel blocker amlodipine (Amlo, 5 to 10 mg) or the ACE- inhibitor lisinopril (Lis, 5 to 10 mg). Throughout the 16-week study period, blood pressure, creatinine clearances, and proteinuria were measured every 2 weeks. In addition, device-measured blood pressure and renal hemodynamic studies were performed at the start and end of the study. Systolic blood pressure fell in the Lis group from 163 ± 7 (SEM) to 140 ± 8 mm Hg (P < .01) and from 157 ± 10 to 147 ± 6 mm Hg in the Amlo group; diastolic blood pressure fell from 101 ± 3 to 86 ± 7 mm Hg in the Lis group and from 98 ± 3 to 91 ± 2 mm Hg in the Amlo group. Renal hemodynamics were not affected by amlodipine treatment, whereas a fall in glomerular filtration rate (GFR) was seen in lisinopril-treated patients (from 55 ± 11 to 50 ± 10 mL/min; P < .01). Amlodipine did not significantly affect proteinuria. Lisinopril induced a decline in the protein-creatinine ratio with a maximal effect reached after 12 to 16 weeks of therapy (from 0.39 ± 0.17 to 0.26 ± 0.11 g/mmol; P < .009). In conclusion, we could not demonstrate an antiproteinuric effect of the long-acting dihydropyridine calcium channel blocker amlodipine, whereas therapy with the ACE-inhibitor lisinopril resulted in a decrease in proteinuria. Amlodipine did not affect renal hemodynamics, whereas lisinopril induced a fall in GFR.

Cite

CITATION STYLE

APA

Janssen, J. J. W. M., Gans, R. O. B., Van Der Meulen, J., Pijpers, R., & Ter Wee, P. M. (1998). Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure a double-blind, randomized prospective study. American Journal of Hypertension, 11(9), 1074–1079. https://doi.org/10.1016/S0895-7061(98)00129-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free